Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederarstechnica.com
Ars Technica
Get the latest updates from Ars Technica directly as they happen.
Follow now 6802 followers
Latest posts
Last updated about 2 hours ago
Roblox must make changes after failing to block adults creeping on kids
about 4 hours ago
Despite making changes last fall to help block adults from messaging unknown...
NASA calls off mission to rescue Swift gamma-ray observatory
about 21 hours ago
NASA and Katalyst Space Technologies announced Wednesday they are giving up on...
Amazon aims for delivery drones to reach 500 US neighborhoods by end of 2026
about 23 hours ago
Amazon wants to grow its Prime Air delivery drone service sixfold to...
The floodgates are open after another Chinese company lands a reusable rocket
1 day ago
It has been a little more than a month since China recovered...
FCC abolishes gigabit speed goal, suggesting it is unfair to slower technologies
1 day ago
The Federal Communications Commission last week eliminated the gigabit speed goal established...
Flight attendants freaked out that Google is buying tons of Spirit employee data
1 day ago
Last Friday, Google won an auction to acquire a huge amount of...
Framework responds to complaints that BIOS update bricks Ryzen 7040 laptops
1 day ago
A BIOS update for the Framework Laptop 13 with AMD Ryzen 7040-series...
Trump expected to pick conservative policy wonk Heidi Overton to lead FDA
1 day ago
President Trump is expected to nominate Heidi Overton, a top conservative policy...
Meta ran ads for an app promising to nudify female politicians
1 day ago
Meta platforms recently ran ads for an AI porn-generation tool that seemingly...
Scientists find closest star to the Milky Way's central black hole
1 day ago
Sgr A* is the name we've given to the supermassive black hole...
Google Pixel 11 series review: Is the magic fading?
1 day ago
Google's approach to making smartphones has changed a lot over the years...
mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say
1 day ago
Pharmaceutical partners Moderna and Merck announced on Wednesday that their novel mRNA-based...